Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioSpace

02:21 EST 11th December 2017 | BioPortfolio

Here are the most relevant search results for "BioSpace" found in our extensive news archives from over 250 global news sources.

More Information about BioSpace on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioSpace for you to read. Along with our medical data and news we also list BioSpace Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioSpace Companies for you to search.

Showing News Articles 1–25 of 17,000+ from BioSpace

Thursday 7th December 2017

SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission

No clinical trials are required for the NDA resubmission.

Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain...

At the meeting, the panel voted 15 to 0 that patients with interstitial cystitis and patients with bladder pain syndrome should be combined in clinical trials.

Pfizer Shows Off Phase III Breast Cancer Data

The data will be presented today as an oral presentation at the 2017 San Antonio Breast Cancer Symposium.

Aeterna Zentaris Interim CFO Departs, Effective Immediately

The Company is currently reviewing its resource requirements with respect to its finance department and has commenced a search for Mr. Whitnell's replacement as principal financial officer.

ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial

Resources redirected to progress new drug candidates to clinic in H1 2018.

ERYTECH's Lead AML Drug Flunks Phase II Test

The study enrolled a total of 123 patients at 30 European sites.

Sweden's Active Biotech is Strapped for Cash and May Not Survive 2018

The Board has also decided to sell the company's property in Lund as a possible way of generating additional liquidity for the company.

Look Out AstraZeneca: Pfizer Shows Off Phase III Breast Cancer Data

The data will be presented today as an oral presentation at the 2017 San Antonio Breast Cancer Symposium.

Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals

Glaxo has a bold future planned for its R&D facility in Maryland.

Sucampo Exploring Sale on Rumored Takeover Interest

The company, which hasn’t made a decision, may still decide against a sale and instead pursue growth through acquisitions, said the people.

Activist Investor Urges Alexion to Sell Itself or Else

Elliott Management has built a stake in Alexion and has urged the biopharma to do more to lift its stock price.

Invacare Takes an Ax to 110 Jobs in North America

The cuts are expected to generate approximately $8.5 million in annualized pre-tax savings.

Biotech Hedge Fund Titan, Isaly, Steps Down Amid Sexual Harassment Claims

He will be replaced as Managing Partner by a Management Committee composed of Sven H. Borho, Carl L. Gordon, and Jonathan T. Silverstein.

Mysterious NuBiyota Inks Lease for Former Pfizer Campus

NuBiyota would not share information about the company or its operations in Pearl River.

Spark's Good Week Continues With Signing of Huge Lease Near HQ

The lease was signed Nov. 20 and will run for 15 years, according to documents Spark filed with the Securities and Exchange Commission.

Ex-Genentech Employees' Denali Breaks 2017 IPO Records, Raises $250M

The company announced the pricing of its IPO of 13,888,888 shares of its common stock at a price to the public of $18.00 per share.

Wednesday 6th December 2017

Vericel to Boost Headcount With Expanded $25M Debt Facilities Deal With Silicon Valley Bank

The cash will support Vericel’s planned MACI sales force expansion from 28 to 40 sales representatives.

Stryker Slams Down $662M for Entellus Medical

Entellus' ENT portfolio is led by e XprESS Multi-Sinus Dilation System and the LATERA Absorbable Nasal Implant.

San Diego's Halozyme Lands Potential $680M R&D Deal With Alexion

Alexion will use Halozyme's ENHANZE drug-delivery technology to develop subcutaneous formulations for that company’s portfolio of products.

Life Science's Fastest Growing Job Right Now

A look at the one position that stands out for its role in the biopharma industry.

2018 Hiring Trends for Life Science Job Hunters

Here are five trends job hunters may see in the life sciences next year.

World's Top 10 Best Biotechs

There are hundreds, even thousands of biotech and pharmaceutical companies.

Unwanted Light Shines on AstraZeneca and Its Blockbuster Seroquel

Taking Seroquel with methadone can be fatal. Did the drugmaker’s warnings fall short?

Top 3 Biotech Stocks to Buy in 2018

Here are three stocks that look particularly promising.

Genentech's Tecentriq-Avastin-Chemo Combo Dazzles in Late-Stage Study

Genentech announced positive results from its Phase III clinical trial of Tecentriq and Avastin with carboplatin and paclitaxel chemotherapy in patients with previously untreated, advanced non-squamous NSCLC.


Quick Search
Advertisement
 

News Quicklinks